Slide 1: 2022 Sustainability Highlights
2022 Sustainability Highlights Conference call for investors and analysts 22 March 2023
Slide 2: Forward-looking statements
Forward-looking statements In order, among other things, to utilise the 'safe harbour' provisions of the US Private Securities Litigation Reform Act of 1995, AstraZeneca (hereafter ‘the Group’) provides the following cautionary statement: this document contains certain forward-looking statements wit
Slide 3: Sustainability at AstraZeneca
Sustainability at AstraZeneca Pam Cheng E X E C U T I V E V I C E P R E S I D E N T, G L O B A L O P E R AT I O N S , I N F O R M AT I O N T E C H N O L O G Y A N D C H I E F S U S TA I N A B I L I T Y O F F I C E R 3 March 2023
Slide 4: Sustainability Governance at AstraZeneca
Sustainability Governance at AstraZeneca Embedding sustainability in everything we do to create value beyond the impact of our medicines Board of Directors (BOD) Leif Johansson BOD Nazneen Rahman BOD Sheri McCoy BOD Non-Executive Chair Non-Executive Director of the Board Chief Human Resources of the
Slide 5: Industry-leading efforts in Sustainability
Industry-leading efforts in Sustainability Building a sustainable future for people, society and the planet Sustainability Ratings Equitable access 3rd overall up from 7th in 2020 Affordability and pricing Bloomberg Gender- Health system Ambition Zero Equity Index constituent for resilience Carbon 5
Slide 6: 2022 Sustainability highlights
2022 Sustainability highlights Progress on our overall Access to Healthcare Environmental protection Ethics and transparency strategy includes: 14 126,684 59.3% 49.5% public and private sector organisations healthcare workers and others trained1 reduction in Scope 1 and Scope 2 senior middle managem
Slide 7: Access to Healthcare
Access to Healthcare Securing a future of access to affordable, sustainable, and innovative healthcare Partnership for Health System Sustainability and Resilience (PHSSR) Our ambition: committed to collaborating to promote prevention, increase across sectors and Co-founded by Has expanded to access
Slide 8: Environmental Protection
Environmental Protection Progress update on Ambition Zero Carbon 59.3% reduction Scope 1 & 2 Scope 3 $50 000 700 000 $1B Ambition Zero Carbon $45 000 Supplier engagement significant projects: 600 000 $40 000 Energize collaboration facilitating access to renewable power at scale Next-generation Scope
Slide 9: Natural Resources and Biodiversity at AstraZeneca
Natural Resources and Biodiversity at AstraZeneca Reinforcing our commitment to ensure the sustainable use of natural resources Approach Reforestation1,2 Water stewardship4 adopting principles of the Circular Economy committed to: through: prioritising: Plant and maintain 50 million trees A rating f
Slide 10: Ethics and Transparency
Ethics and Transparency Ensuring ethical, open and inclusive behaviour across our organisation and value chain With a key focus on: Ethical business culture Inclusion and diversity Workforce safety and health I. Human Rights committed to: External Ratings: Committed to: Guiding Principles of human r
Slide 11: Question & Answer Session
Question & Answer Session Pam Cheng EXECUTIVE VICE PRESIDENT, GLOBAL Juliette White OPERATIONS, INFORMATION VICE PRESIDENT, GLOBAL SHE AND TECHNOLOGY AND CHIEF OPERATIONS SUSTAINABILITY SUSTAINABILITY OFFICER Stefan Weber Bryan Mulchinock GLOBAL HEAD OF POLICY HEAD OF ENVIRONMENT, HEALTH AND SAFETY
Slide 12: Appendix
Appendix • Access to Medicines Index: Performance Summary • Access in Action: Healthy Heart Africa • Access in Action: Accelerate Change Together 12
Slide 13: 2022 Access to Medicines Index
2022 Access to Medicines Index Continuous improvement across three pillars 2022 Score: 3.93 Governance of Access (2nd) 4.43 3rd in 2022 Research & Development (6th) 3.03 Product Delivery (1st) 4.29 AstraZeneca ATMi Rating History 5.0 2021 4.0 3.93 Score: 3.30 Governance of Access (3rd) 4.32 3.30 3.0
Slide 14: Healthy Heart Africa
Healthy Heart Africa Improving access to end-to-end hypertension management Driven by: Targeted interventions leveraging existing healthcare systems and initiatives Focus on hypertension including screening, diagnosis and treatment 1,258 Integrated activities healthcare facilities activated in 2022
Slide 15: Accelerate Change Together
Accelerate Change Together Improving cancer care in Africa Capacity and Enhancing screening Patient capability building and diagnostics empowerment Aiming to improve the quality of care Aiming to cover Advocating for expanded access to provided to patients across the region through: 1,000,000 screen
Slide 16: Use of AstraZeneca slides from conference calls and webcasts
Use of AstraZeneca slides from conference calls and webcasts The AstraZeneca webcast, conference call and presentation slides (together the ‘AstraZeneca materials’) are for your personal, non-commercial use only. You may not copy, reproduce, republish, post, broadcast, transmit, make available to th